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Objective: The purpose of this study is to estimate the frequency of Mycobacterium chelonae
among tuberculosis suspected patients in Basra Governorate and to evaluate the antimicro-
bial susceptibility.
Methods: After isolation of M. chelonae from 100 samples from patients admitted to the
RPDC, smears were stained with the Ziehl Neelsen technique. Specimens were inoculated
on Lowenstein Jensen medium. Identification to species level was achieved on the basis of
the growth characteristics. Drug susceptibility was tested with antibiotics (Rifampicin,
Isoniazid, Ethambutol, Pyrazinamide and Streptomycin) using proportional method.
Results: From the 100 sputum samples among tuberculosis suspected patients, 16 samples
(16%) were Non-tuberculosis mycobacterium (NTM), 4 (4%) were M. chelonae. Drug
susceptibility results showed all isolates resistant to rifampicin, while one isolate showed
intermediate resistance to ethambutol. Also, all isolates of M. chelonae were sensitive to
pyrazinamide, isoniazid and streptomycin.
Conclusion: The results of this study emphasize that M. chelonae presents with high fre-
quency, especially among tuberculosis suspected patients, which requires confirmation
on a follow-up visit, along with the examination of patterns of sensitivity, and it is an
absolute necessity in addition to the approximate hour patients typically spend in health
centers in Iraq.
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